Correspondence  by unknown
LETTERS TO THE EDITOR
Milking In Hypertrophic Cardiomyopathy
Yetman et al. (1) retrospectively reviewed angiograms performed
over 40-years in children with hypertrophic cardiomyopathy
(HCM). Ten (28%) of 36 children had a myocardial bridge that
was associated with an adverse prognosis. They suggested that
myocardial bridging may cause ischemia and represents a risk
factor for sudden death (1). Clarification of some methodologic
aspects is important, given the potential importance of this finding.
The criteria used to select children for coronary angiography are
unclear. Coronary milking is a dynamic phenomenon. In this
regard, no information was provided on medications at the time of
angiography (e.g., whether intracoronary nitroglycerin was admin-
istered or whether the bridging was visualized after specific
maneuvers to elicit intraventricular gradients) (1,2). Despite severe
myocardial bridging (.90% systolic diameter narrowing, extend-
ing 50 6 17% of the diastolic period), the diagnosis of the
phenomenon was initially made in only three patients (2). In our
experience, ventricular arrhythmias are uncommon in children
with HCM and are usually asymptomatic (3). This is in contrast
with the high incidence of ventricular tachycardia (21 [27%] of 78
patients, 9 of whom were symptomatic) in the present study (1).
Symptomatic sustained ventricular tachycardia is rare in HCM and
has been associated with apical ventricular aneurysms (4). A more
detailed description of the patients with ventricular arrhythmia
seems warranted. The presence of wall motion abnormalities
would further support the hypothesis of myocardial bridging as the
cause of ischemia.
Children with HCM are at greater risk of sudden death, yet risk
stratification is particularly challenging in children (3). There is
debate over the significance of myocardial bridging. Although the
hypothesis of Yetman et al. (1) is attractive, they fail to provide
conclusive evidence that myocardial bridging induced ischemia. In
addition, the exact mechanism leading to ventricular arrhythmias
and sudden death remains elusive. We are concerned by the
potential implications of this study. Should selective coronary
angiography be included in the diagnostic assessment of most
children with HCM, or should it only be reserved for those
requiring more precise risk stratification? We believe that owing to
the high incidence of milking among low risk adult patients with
HCM (2), coronary angiography should only be considered for
children with recognized risk factors (e.g., recurrent syncope,
strong family history of sudden death) or for those with refractory
symptoms. We are also worried by the possibility that coronary
revascularization may now be easily contemplated if a myocardial
bridge is demonstrated. In fact, coronary stenting seems to be a
much more attractive strategy for these children than the classic
surgical “unroofing.” Although initial results of coronary stenting
in this setting seem favorable, a relatively high restenosis rate (or
rather, stent stenosis) has been reported (5). Furthermore, we have
previously demonstrated (6) that coronary stenting itself may
induce the appearance of systolic coronary narrowing at a different
site.
We write not to “fire bullets” at what is a potentially useful
observation, but rather to clarify the context and practical aspects
in relation to the significance of myocardial bridging in children
with HCM.
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REPLY
We thank Drs. McKenna and Alfonso for their comments. Our
report (1) was a review of a large heterogeneous population of
children with hypertrophic cardiomyopathy (HCM). Within this
population, a subgroup of patients with myocardial bridging was
identified. This patient group was further studied and is the focus
of a recent paper (2). The authors’ comments and criticisms appear
to be primarily directed toward that paper.
To clarify, routine angiograms with coronary evaluation were
performed in all patients with symptoms suggestive of myocardial
ischemia (chest pain, syncope or resuscitated sudden death), either
before surgical myectomy or to confirm the diagnosis of HCM
before the routine use of two-dimensional echocardiography. No
medications or maneuvers were used to elicit systolic compression
of the coronary arteries.
We have noted an increased incidence of ventricular tachycardia
in those patients with myocardial bridging demonstrated by
angiography (2). Of note is that, these patients had a significantly
lower blood pressure response to exercise (2), which is thought to
confer a poor prognosis (3) and which occurs secondary to
myocardial ischemia (4). To further support this hypothesis, we
have identified myocardial perfusion abnormalities on thallium
imaging in those patients with myocardial bridging (2). Annual
examination, with 48-h Holter monitoring allowed us to identify
ventricular tachycardia in this high risk group of patients (2).
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